In this cohort of mainly high-risk PCa, the results revealed no significant correlation between [68Ga]Ga-PSMA-11 perfusion and consumption and the aggressiveness of the primary prostate tumor. The gene discussed is FOLH1; the disease is posterior cortical atrophy.